BP Equities IG Petrochemicals Ltd Q3FY19 Result U
BP Wealth
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
11 Feb 2019 | I G Petrochemicals |
BP Wealth
|
428.80 | 512.00 | 220.90 (94.11%) |
Buy
|
|||||
11 Feb 2019 | Orient Cement |
Chola Wealth Direct
|
217.21 | 81.00 | 65.75 (230.36%) | Target met |
Buy
|
||||
11 Feb 2019 | Insurance |
Prabhudas Lilladhar
|
Sector Update
|
Sector Update - Steady growth trends for private players
Prabhudas Lilladhar
Mid-sized continue to lead growth: From last few months mid-sized players have been seeing strong growth especially from TATA AIA/Birla MF scoring Source: Life Insurance Council, PL from Banca, while Max and Bajaj Life improving its proprietary channel sourcing. Mid-sized have also seen higher growth on back continuous addition to product line in both individual & group segments trying to reach in-line with larger player offerings. ABSLI continued its industry leading growth at 84% YoY, Max Life grew at strong 35% YoY over the base of 64%registered in...
|
|||||||
11 Feb 2019 | N R Agarwal Industries |
Prabhudas Lilladhar
|
407.45 | 465.00 | 300.10 (35.77%) |
Buy
|
Quarter result impacted by plant shut down
Prabhudas Lilladhar
Revenues were flat at Rs 3,158m both YoY and QoQ due to volume decline of 10.5% YoY and 1.8% QoQ at 71,099 tons. Newsprint (NP) volumes dip by 53.3% to 5,333 tons. During the quarter, Unit II was shut down for 30 days for plant upgradation to Writing & Printing (W&P;) business,...
|
||||
11 Feb 2019 | Aurobindo Pharma |
Prabhudas Lilladhar
|
1027.90 | 952.00 | 764.65 (34.43%) |
Buy
|
Q3FY19 Result Update - Q3 beats estimates; Poised to monetize Onco Inj
Prabhudas Lilladhar
The Q3FY19 sales, adj. EBITDA and PAT beat our estimates by 9%, 3% and Change in Estimates | Target | Reco 8% respectively. While the injectable business was in line with guidance, its flat value erosion of US generics QoQ and efficient execution of new business...
|
||||
11 Feb 2019 | I G Petrochemicals |
Prabhudas Lilladhar
|
428.80 | 530.00 | 220.90 (94.11%) |
Buy
|
Q3FY19 Result Update - After a weak Q3, on a recovery mode
Prabhudas Lilladhar
Strong downstream demand from diverse user industries and limited global capacity additions to help sustain PAN demand. We lower our FY20/21E estimates to factor in lower EBIDTA margins (17% vs 20% earlier) and delay in commissioning of new project. IGPL's planned...
|
||||
11 Feb 2019 | JK Cement |
Prabhudas Lilladhar
|
6946.50 | 692.00 (903.83%) |
Hold
|
Q3FY19 Result Update - Disappoints on cost; Price outlook remains weak
Prabhudas Lilladhar
JK Lakshmi Cement (JKLC) reported Q3FY19 earnings below our estimates Change in Estimates | Target | Reco due to higher than expected costs. JKLC's investments in Waste Heat recovery (WHR) plant at Durg, Chhattisgarh unit and other cost rationalization...
|
|||||
11 Feb 2019 | Britannia Industries |
Prabhudas Lilladhar
|
5824.00 | 3159.00 | 3119.90 (86.67%) | Target met |
Accumulate
|
Q3FY19 Result Update - Innovations to power growth
Prabhudas Lilladhar
Britannia is entering a new phase of growth powered by innovations and Change in Estimates | Target | Reco renovations like 1) Whole Wheat Vita Marie Gold, Goodday Cashew Almond, re-launches in 50-50 & Tiger Creams 2) significant revamp of cakes portfolio...
|
|||
11 Feb 2019 | Dr. Lal Pathlabs |
Prabhudas Lilladhar
|
3308.90 | 1070.00 | 1021.10 (224.05%) | Target met |
Accumulate
|
Q3FY19 Result Update - Q3 in line; Muted Dengue season leads tepid Q3
Prabhudas Lilladhar
DLPL's revenue, adj. EBITDA and PAT grew 11%, 16% and 27% YoY Change in Estimates | Target | Reco respectively in Q3FY19 and in line with our estimates in margin and earnings. With strong cash flow and growth in new customers and packaged offer, the...
|
|||
11 Feb 2019 | Insurance |
Prabhudas Lilladhar
|
Sector Update
|
Sector Update - Steady growth trends for private players
Prabhudas Lilladhar
Mid-sized continue to lead growth: From last few months mid-sized players have been seeing strong growth especially from TATA AIA/Birla MF scoring Source: Life Insurance Council, PL from Banca, while Max and Bajaj Life improving its proprietary channel sourcing. Mid-sized have also seen higher growth on back continuous addition to product line in both individual & group segments trying to reach in-line with larger player offerings. ABSLI continued its industry leading growth at 84% YoY, Max Life grew at strong 35% YoY over the base of 64%registered in...
|
|||||||
more
loading
|